I was under the impression that Dr Yo was looking

I was under the impression that Dr Yo was looking at use of generic medicines like steroids to treat longhaulers . In Asia ,Eg Hong Kong and Singapore they used steroids to treat SARS ,and it appears they have done much better from the outset with Covid treatment . Check the stats for Singapore.
Second point re possible bias of Dr Patterson ; It's hardly credible to sing his praise for months ,then suddenly turn and say ,oh he just wants to sell test kits.
Cost of treatment is very important,for most people on the planet , expensive treatment will be out of financial reach, so the use of generic medicines,if they work adequately is at the very least valid. There will be very few people in the Philippines ,for example, who could afford $1000 for treatment. Ive lived there and travelled in other third world countries,and know , from experience that this is the case.
Generally, regarding Cytodyn, I'm concerned at this strategy of pursuing Covid treatment ,as I doubt that there will be much financial profit in it, especially with improving standard of care,and the likely competition. In particular I am dismayed at this 25 million loan , which cost 28 million,and carries 10% interest. Would have been infinitely preferable to have issued 20 million shares at $4.00 for example.
Related to my concern of the pursuit of corona treatment is that given the marketing power of large pharma companies, I expect it will be very difficult to gain any significant market share,and certainly don't believe that leronlimab will sell itself,no need for marketing ,as one highly respected poster here insisted on ,a few months back. That is naive and doesn't reflect the reality of the relationship between doctors ,drugs ,and pharmaceutical companies.
These concerns don't mean I am negative on CYDY as a whole ,one always has to balance up the good and the bad with these type of investments.